Phosphorylation of Cardiac Troponin I at Protein Kinase C Site Threonine 144 Depresses Cooperative Activation of Thin Filaments

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Feb 19

PMID 20164197

Citations 27

Authors

Qun-Wei Lu

Aaron C Hinken

Stacey E Patrick

R John Solaro

Tomoyoshi Kobayashi

Affiliations

Soon will be listed here.

Abstract

There is evidence for PKC-dependent multisite phosphorylation of cardiac troponin I (cTnI) at Ser-23 and Ser-24 (also PKA sites) in the cardiac-specific N-terminal extension and at Thr-144, a unique residue in the inhibitory region. The functional effect of these phosphorylations in combination is of interest in view of data indicating intramolecular interaction between the N-terminal extension and the inhibitory region of cTnI. To determine the role of PKC-dependent phosphorylation of cTnI on sarcomeric function, we measured contractile regulation at multiple levels of complexity. Ca(2+) binding to thin filaments reconstituted with either cTnI(wild-type) or pseudo-phosphorylated cTnI(S23D/S24D), cTnI(T144E), and cTnI(S23D/S24D/T144E) was determined. Compared with controls regulated by cTnI(wild-type), thin filaments with cTnI(S23D/S24D) and cTnI(S23D/S24D/T144E) exhibited decreased Ca(2+) sensitivity. In contrast, there was no significant difference between Ca(2+) binding to thin filaments with cTnI(wild-type) and with cTnI(T144E). Studies of the pCa-force relations in skinned papillary fibers regulated by these forms of cTnI yielded similar results. However, in both the Ca(2+) binding measurements and the skinned fiber tension measurements, the presence of cTnI(S23D/S24D/T144E) induced a much lower Hill coefficient than either wild type, S23D/S24D, or T144E. These data highlight the importance of thin filament-based cooperative mechanisms in cardiac regulation, with implications for mechanisms of control of function in normal and pathological hearts.

Citing Articles

Fluorescence lifetime-based assay reports structural changes in cardiac muscle mediated by effectors of contractile regulation.

Dvornikov A, Bunch T, Lepak V, Colson B J Gen Physiol. 2023; 155(3).

PMID: 36633587 PMC: 9859762. DOI: 10.1085/jgp.202113054.

A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.

Qvit N, Lin A, Elezaby A, Ostberg N, Campos J, Ferreira J Pharmaceuticals (Basel). 2022; 15(3).

PMID: 35337069 PMC: 8950820. DOI: 10.3390/ph15030271.

Troponin I modulation of cardiac performance: Plasticity in the survival switch.

Biesiadecki B, Westfall M Arch Biochem Biophys. 2019; 664:9-14.

PMID: 30684464 PMC: 6403007. DOI: 10.1016/j.abb.2019.01.025.

A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats.

Ferreira J, Campos J, Qvit N, Qi X, Bozi L, Bechara L Nat Commun. 2019; 10(1):329.

PMID: 30659190 PMC: 6338754. DOI: 10.1038/s41467-018-08276-6.

Functional communication between PKC-targeted cardiac troponin I phosphorylation sites.

Lang S, Stevenson T, Schatz T, Biesiadecki B, Westfall M Arch Biochem Biophys. 2017; 627:1-9.

PMID: 28587770 PMC: 5555030. DOI: 10.1016/j.abb.2017.05.019.

References

Mittmann K, Jaquet K, Heilmeyer Jr L . Ordered phosphorylation of a duplicated minimal recognition motif for cAMP-dependent protein kinase present in cardiac troponin I. FEBS Lett. 1992; 302(2):133-7. DOI: 10.1016/0014-5793(92)80423-e. View

Tobacman L, Sawyer D . Calcium binds cooperatively to the regulatory sites of the cardiac thin filament. J Biol Chem. 1990; 265(2):931-9. View

Mathur M, Kobayashi T, Chalovich J . Negative charges at protein kinase C sites of troponin I stabilize the inactive state of actin. Biophys J. 2007; 94(2):542-9. PMC: 2157249. DOI: 10.1529/biophysj.107.113944. View

Kobayashi T, Yang X, Walker L, van Breemen R, Solaro R . A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C. J Mol Cell Cardiol. 2004; 38(1):213-8. DOI: 10.1016/j.yjmcc.2004.10.014. View

Zhang R, Zhao J, Potter J . Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C. J Biol Chem. 1995; 270(51):30773-80. DOI: 10.1074/jbc.270.51.30773. View

Hunlich M, Begin K, Gorga J, Fishbaugher D, LeWinter M, VanBuren P . Protein kinase A mediated modulation of acto-myosin kinetics. J Mol Cell Cardiol. 2004; 38(1):119-25. DOI: 10.1016/j.yjmcc.2004.10.005. View

Tobacman L . Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol. 1996; 58:447-81. DOI: 10.1146/annurev.ph.58.030196.002311. View

Molkentin J, Dorn 2nd G . Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol. 2001; 63:391-426. DOI: 10.1146/annurev.physiol.63.1.391. View

Tachampa K, Wang H, Farman G, de Tombe P . Cardiac troponin I threonine 144: role in myofilament length dependent activation. Circ Res. 2007; 101(11):1081-3. DOI: 10.1161/CIRCRESAHA.107.165258. View

10.

Reiffert S, Jaquet K, Heilmeyer Jr L, Ritchie M, Geeves M . Bisphosphorylation of cardiac troponin I modulates the Ca(2+)-dependent binding of myosin subfragment S1 to reconstituted thin filaments. FEBS Lett. 1996; 384(1):43-7. DOI: 10.1016/0014-5793(96)00274-8. View

11.

Pi Y, Kemnitz K, Zhang D, Kranias E, Walker J . Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ Res. 2002; 90(6):649-56. DOI: 10.1161/01.res.0000014080.82861.5f. View

12.

Moss R, Razumova M, Fitzsimons D . Myosin crossbridge activation of cardiac thin filaments: implications for myocardial function in health and disease. Circ Res. 2004; 94(10):1290-300. DOI: 10.1161/01.RES.0000127125.61647.4F. View

13.

Hanft L, Korte F, McDonald K . Cardiac function and modulation of sarcomeric function by length. Cardiovasc Res. 2007; 77(4):627-36. DOI: 10.1093/cvr/cvm099. View

14.

Phan T, Abozguia K, Shivu G, Mahadevan G, Ahmed I, Williams L . Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol. 2009; 54(5):402-9. DOI: 10.1016/j.jacc.2009.05.012. View

15.

Noland Jr T, Raynor R, Kuo J . Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J Biol Chem. 1989; 264(34):20778-85. View

16.

Lu Q, Morimoto S, Harada K, Du C, Takahashi-Yanaga F, Miwa Y . Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization. J Mol Cell Cardiol. 2003; 35(12):1421-7. DOI: 10.1016/j.yjmcc.2003.09.003. View

17.

Pan B, Solaro R . Calcium-binding properties of troponin C in detergent-skinned heart muscle fibers. J Biol Chem. 1987; 262(16):7839-49. View

18.

Finley N, Rosevear P . Introduction of negative charge mimicking protein kinase C phosphorylation of cardiac troponin I. Effects on cardiac troponin C. J Biol Chem. 2004; 279(52):54833-40. DOI: 10.1074/jbc.M408304200. View

19.

Regnier M, Martin H, Barsotti R, Rivera A, Martyn D, Clemmens E . Cross-bridge versus thin filament contributions to the level and rate of force development in cardiac muscle. Biophys J. 2004; 87(3):1815-24. PMC: 1304586. DOI: 10.1529/biophysj.103.039123. View

20.

Noland Jr T, Guo X, Raynor R, Jideama N, Averyhart-Fullard V, Solaro R . Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem. 1995; 270(43):25445-54. DOI: 10.1074/jbc.270.43.25445. View